Our founder and CEO Fertram Sigurjonsson & VP Payor & Provider Relations Gunnar Jóhannsson MD attended the Cure Melanoma Scientific Meeting

Kerecis participated in the Melanoma Research Alliance​ – Scientific Retreat this week. With rapidly improving survival rates, new cancer treatments lead to high risk of wound dehiscence and graft failure. Kerecis Omega3 rich fish skin decreases postsurgical complications and improves outcomes

To read more about the event visit there page: https://www.curemelanoma.org/